Marta
Vázquez Cedeira
Investigadora desde 2017
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (7)
2018
-
VRK1 and AURKB form a complex that cross inhibit their kinase activity and the phosphorylation of histone H3 in the progression of mitosis
Cellular and Molecular Life Sciences, Vol. 75, Núm. 14, pp. 2591-2611
2014
-
VRK1 interacts with p53 forming a basal complex that is activated by UV-induced DNA damage
FEBS Letters, Vol. 588, Núm. 5, pp. 692-700
-
Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting dna damage response
Oncotarget, Vol. 5, Núm. 7, pp. 1770-1778
2013
-
Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression
Cell Death and Disease, Vol. 4, Núm. 2
-
Sensitivity of the kinase activity of human vaccinia-related kinase proteins to toxic metals
Journal of Biological Inorganic Chemistry, Vol. 18, Núm. 4, pp. 473-482
-
VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosis
BMC Clinical Pathology, Vol. 13, Núm. 1
2012
-
Human VRK2 (vaccinia-related kinase 2) modulates tumor cell invasion by hyperactivation of NFAT1 and expression of cyclooxygenase-2
Journal of Biological Chemistry, Vol. 287, Núm. 51, pp. 42739-42750